Srijita Bhowmik
About Srijita Bhowmik
Srijita Bhowmik is a scientist specializing in medicinal chemistry and drug development, currently working at Arcus Biosciences. She has extensive experience in analytical techniques and collaborates with cross-functional teams to advance drug discovery efforts.
Current Role at Arcus Biosciences
Srijita Bhowmik currently serves as a Scientist in Medicinal Chemistry, Research & Drug Development at Arcus Biosciences. She has been in this role since 2022, contributing to drug discovery efforts in Hayward, California. Her responsibilities include utilizing advanced analytical techniques and collaborating with cross-functional teams to enhance the development of new therapeutic compounds.
Previous Experience in Research and Development
Prior to her current position, Srijita Bhowmik held several roles in research and development. She worked as a Senior Scientist in Process Chemistry & Technology at TCG GreenChem Inc. from 2021 to 2022. Additionally, she served as a Graduate Research Assistant at Columbia University from 2016 to 2021, where she focused on organic chemistry under the guidance of Professor Dalibor Sames. Her experience also includes roles at the Indian Institute of Technology, Kanpur, and the Jawaharlal Nehru Centre for Advanced Scientific Research.
Educational Background in Chemistry
Srijita Bhowmik has a strong educational foundation in chemistry. She earned her Doctor of Philosophy (PhD) in Organic Chemistry from Columbia University from 2016 to 2021. Prior to that, she completed her Master of Science (MS) in Chemistry at the Indian Institute of Technology, Kanpur from 2014 to 2016, and her Bachelor of Science (BS) in Chemistry at Presidency University from 2011 to 2014.
Technical Skills and Analytical Techniques
Srijita Bhowmik is proficient in advanced analytical techniques essential for medicinal chemistry. She utilizes methods such as High-Performance Liquid Chromatography (HPLC), Liquid Chromatography-Mass Spectrometry (LC-MS), Gas Chromatography-Mass Spectrometry (GC-MS), and Nuclear Magnetic Resonance (NMR) for compound purification and structural analysis. Additionally, she employs software tools like GraphPad, ChemDraw, and PyMOL for data analysis and molecular modeling.
Collaborative Research and Drug Discovery
In her roles, Srijita Bhowmik actively collaborates with cross-functional teams, including biologists, pharmacologists, and toxicologists. This collaboration aims to enhance drug discovery efforts and optimize small molecules for clinical development. She stays informed about emerging technologies and scientific literature in the field, contributing to the advancement of drug discovery projects through modern synthetic methodology development.